Sickle cell anemia patient with sarcoidosis-associated inguinal lymph node and lung infiltration

Journal of the National Medical Association

Volumn 97, Issue 6, 2005, Pages 820-822

  Güvenç, Birol ^a,d   Unsal, Cagatay ^a   Hanta, Ismail ^a   Unsal, Aydan ^b   Güvenç, Hakan ^c  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c MERSIN STATE HOSPITAL   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Hemoglobinopathy; Sarcoidosis; Sickle cell anemia

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HEMOGLOBIN S; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ARTICLE; BLOOD SMEAR; BRONCHOSCOPY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; COUGHING; DISEASE ASSOCIATION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GRANULOMATOUS INFLAMMATION; HEART FAILURE; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LABORATORY TEST; LUNG INFILTRATE; LYMPH NODE BIOPSY; MUSCLE WEAKNESS; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SARCOIDOSIS; SICKLE CELL ANEMIA; THORAX RADIOGRAPHY;

ANEMIA, SICKLE CELL; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPH NODES; LYMPHATIC DISEASES; METHYLPREDNISOLONE; MIDDLE AGED; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 20344394445     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Baughman RP, Elyse E, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003; 361:1111-1118.
2. Hunninghake GW, Costabel U, Ando M, et al. Statement on bronchoalveolar and serological parameters reflecting the severity of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149-173.
3. Drent M. Sarcoidosis: benefits of a multidisciplinary approach. European Journal of Internal Medicine. 2003;14:217-220.
4. Harmening DM. Hemolytic Anemias: Intracorpuscular Defects, Chapter 11, Clinical Hematology and Fundamentals of of Hemostasis, 3rd ed. Harmening DM, ed. Philadelphia: FA Davis Co. 1997;173-210.
5. Boros L, Thomas C, Weiner WJ. Large cerebral vessels in sickle cell anemia. J Neurol Neurosurg Psychiatry. 1976;39:1236-1239.
6. Poward D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;65:462-471.
7. Hall G, Carter J. Sarcoidosis and sickle cell disease. Ann Intern Med. 1993;118:157-158.
8. Chan ED, Terada LS, Schwarz MI. Sarcoidosis presenting with prolonged fever in a patient with sickle cell anemia. J Natl Med Assoc. 1995;87:826-828.
9. Zwerdling T, Kalinyak K, Rucknagel D. Sarcoidosis in a child with sickle cell anemia. Am J Pediatr Hematol Oncol. 1994;16:278-282.
10. Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho. 1994;52:1438-1442.
11. Bardinas F, Morera J, Fite E, et al. Seasonal clustering of sarcoidosis. Lancet. 1989;2:455-456.
12. Hosoda Y, Hiraga Y, Odaka M, et al. A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. Ann N Y Acad Sci 1976;278:355-367.
13. Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax. 1988;43:342-343.
14. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974;99:250-257.
15. Hennessy TW, Ballard DJ, DeRemee RA, et al. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, MN, 1935-1984. J Clin Epidemiol. 1988;41:565-570.
16. Kern DG, Neill MA, Wrenn DS, et al. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis. 1993;148:974-980.
17. Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence and severity of sarcoidosis in New York City firefighters. Chest 1999;116:1183-93.
18. Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med. 1997;156:1000-1003.
19. Hance AJ. The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect. 1998;13:197-205.
20. McGrath DS, Goh N, Foley PJ, et al. Sarcoidosis genes and microbes: soil or seed. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:149-164.
21. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet. 1999;354:120-123.
22. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung lymphocytes in active pulmonary sarcoidosis. N Engl J Med. 1983; 308:793-800.
23. Shigehara K, Shijubo N, Ohmichi M, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol. 2001; 166:642-649.
24. Ziegenhagen MW, Benner UK, Zissel G, et al. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL 2R are prognostic markers. Am J Respir Crit Care Med. 1997;156:1586-1592.
25. Baughman RP, Keeton D, Lower EE. Relationship between interleukin-8 and neutrophils in the BAL fluid of sarcoidosis. Sarcoidosis. 1994;11:S217-S220.
26. Baughman RP, Strohofer SA, Buchsbaum J, et al. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med. 1990;115:36-42.
27. Koffi KG, Sawadogo D, Meite M, et al. Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anemia patients with splenic defects. Hematol J. 2003;4:363-365.
28. Taylor SC, Shacks SJ, Qu Z, et al. Type-2 cytokine serum level in healthy sickle cell disease patients. J Natl Med Assoc. 1997;89:753-757.
29. Bourantas KL, Dalekos GN, Makis A, et al. Acute-phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol. 1998;61:49-54.
30. Taylor SC, Shacks SJ, Qu Z. In-vivo production of type-1 cytokines in healthy sickle cell disease patients. J Natl Med Assoc. 1999;91:619-624.
31. Duits AJ, Schnog JB, Lard LR, et al. Elevated Il-8 levels during sickle cell crisis. Eur J Haematol. 1998;61:302-305.
32. Abboud MR, Taylor EC, Habib D, et al. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000;111:482-490.
33. Yee AMF, Pochabin MB. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-a therapy. Ann Intern Med. 2001;135: 2n7-31.